Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The PlexusDx Precision Peptide Genetic Test analyzes FTO (rs9939609) and MC4R (rs17782313) variants that relate to GLP-1 and related signaling pathways
Temporal trends in incidence rates of lower extremity amputation and associated risk factors among patients using Veterans Health Administration services from 2008 to 2018
We invite you to explore Infusion for Health
Manufacturers now sell directly to cash-paying patients at prices well below the numbers printed on a pharmacy shelf tag, insurers have been rewriting obesity coverage rules year over year, and the compounding market has shifted along with federal shortage designations
Cost, Access, and Treatment Flexibility PlexusDx offers compounded tirzepatide injection at $289/mo month-to-month, or from $249/mo on the 6-month plan across all commitment tiers, with consistent pricing regardless of dose levelyour dose may need to go up, your price won't
The company plans to submit orforglipron for approval as an obesity medication to global regulatory agencies by the end of the year, and as a diabetes medication in 2026
